Tags: Monoclonal AntibodiesCancerAntibody ResearchBispecific AntibodiesDLBCL Trials
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
2 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ||
3 | Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. | ||
4 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
5 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | Protein-Design Startup Archon Adds $20M to Show How ‘Cages’ Can Change Antibody Drugs - 4 months ago | |
6 | Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England | ||
7 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 12 months ago Study: Monoclonal Antibodies Benefit Those Previously Treated for HIV - over 1 year ago | |
8 | John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. | Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus - 6 months ago | |
9 | PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom | Oncimmune announces new contract with global pharma company - 6 months ago | |
10 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | Boosting the Efficiency of Therapeutic Antibody Development - 7 months ago Problems and Solutions for Rapid Antibody Production - 10 months ago Building Broader B Cell Diversity for Better Monoclonal Antibody Discovery - about 1 year ago Building Broader B Cell Diversity for Better Monoclonal Antibody Discovery - about 1 year ago |